For two years, the reported numbers have made this company look worse than the business underneath it.
That is starting to change, and if recurring cash flow keeps improving, the next few quarters could force you to look at the company differently.

Hidden Tax Breaks (Sponsored)
Capital gains taxes may quietly reduce more of your investment returns than you realize.
But the tax code includes several strategies that may help reduce that bill.
Three often-overlooked areas include investment-related expenses, cost basis adjustments, and real estate selling costs.
When structured correctly, these deductions may help minimize taxable gains.
Because the rules can be complex, many investors work with fiduciary financial advisors to plan tax-efficient strategies.
Use SmartAsset’s free tool to find vetted financial advisors serving your area.

Airlines
Allegiant’s $140 Million Synergy Plan Is Hiding Behind a 9x Earnings Multiple

Allegiant Travel Company (NASDAQ: ALGT) picked up fresh support after UBS upgraded the stock to Buy with a $107 target, calling it a top small and mid-cap airline idea. The firm believes investors are underestimating what the combined Allegiant and Sun Country business can earn once integration benefits mature.
Management expects at least $140 million of annual run-rate synergies from the Sun Country acquisition. Q2 already showed better momentum, with adjusted EPS rising 78% to $2.19, adjusted EBITDA reaching $157.7 million, and standalone unit revenue climbing 24.6%.
Around $78, Allegiant trades near 9 times UBS’s 2027 EPS estimate of roughly $9. That leaves you paying a restrained multiple before the full synergy program arrives, while management still guides for more than $6 of adjusted EPS this year.
The Deal Can Change the Earnings Base
Sun Country adds charter, cargo, international leisure routes, and additional network flexibility to Allegiant’s existing operation. If integration delivers close to management’s targets, the combined company can produce more earnings meaningfully without depending entirely on stronger airline pricing or a major rebound in travel demand.
Airline Economics Still Demand Caution
Fuel prices remain volatile, quarterly earnings can swing sharply, and Allegiant carries substantial debt after the acquisition. Integration problems would also weaken the argument for a higher multiple, but your starting valuation already reflects considerable skepticism as the company works toward a larger, more diversified earnings base.

Housing
Century Communities Has $90 of Book Value Behind a $60 Stock

Century Communities Inc. (NYSE: CCS) is trading at a steep discount as high mortgage rates continue to weigh on homebuilder valuations. Evercore recently noted that smaller builders have fallen below historically depressed book-value levels, drawing renewed attention to companies such as Century.
Century ended Q2 with a record book value of $90.24 per share, while the stock trades around $60. That values the company at roughly 0.67 times book even though Q2 net income reached $36.1 million and earnings per share increased 11% from a year earlier.
Management is already taking advantage of the gap, repurchasing about 353,000 shares for $19.6 million during Q2 at a substantial discount to book value. You also have a business that increased deliveries 25% sequentially and raised the lower end of its full-year delivery outlook.
Management Is Buying the Discount
Century now operates a record 330 communities and expects to deliver 9,750 to 10,500 homes this year. Continued repurchases below book can boost per-share value, while a higher community count gives earnings room to recover when affordability eventually improves.
Housing Affordability Remains the Test
Mortgage rates above 7%, heavy buyer incentives, and potential pressure on home prices can all keep margins restrained, while Century still carries meaningful debt. But with book value continuing to rise and the shares trading at roughly two-thirds of that figure, your valuation case does not require a housing boom, only evidence that current conditions are not permanently depressed.

Top Picks (Sponsored)
Only a tiny percentage of stocks meet the criteria for this report.
Analysts have released a new edition highlighting seven names selected using multiple indicators.
Recent picks have delivered notable short-term gains, though results can vary.
The latest report is now available for a limited time.
Download the free report today.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Packaging
Smurfit Westrock’s $7 Billion EBITDA Target Sits Behind a 7x Multiple

Smurfit Westrock plc (NYSE: SW) is getting fresh attention as investors look beyond AI for cheaper growth opportunities. The packaging giant currently guides for $4.9 billion to $5.1 billion of adjusted EBITDA this year while continuing to reshape the business created by its major merger.
With enterprise value around $35 billion, Smurfit Westrock trades near 7 times guided adjusted EBITDA. Management’s longer-term plan targets roughly $7 billion of EBITDA by 2030, about 300 basis points of margin expansion, and approximately $14 billion of cumulative discretionary free cash flow.
The opportunity rests on execution, not a booming packaging market. You have a company closing inefficient facilities, improving its cost structure, and targeting substantially higher margins before assigning much value to future buybacks or additional debt reduction.
The Merger Still Has More Value to Release
Management expects restructuring, pricing actions, and a more efficient manufacturing footprint to lift earnings over the coming years. If EBITDA moves meaningfully toward the $7 billion target while leverage falls, the current enterprise valuation can become considerably cheaper without requiring investors to assign the stock an aggressive multiple.
Debt Keeps Expectations Grounded
Smurfit Westrock still carries substantial debt, packaging demand is cyclical, and higher energy and freight costs have pressured margins, so the 2030 targets deserve caution. Still, your valuation case starts near 7 times current guided EBITDA, with a roughly 4% dividend yield and several years of potential margin improvement and capital returns still ahead.

Actionable Picks This Week
Trimble (NASDAQ: TRMB)
Trimble spent two years turning itself from a hardware company into a subscription software business, and that transition does something ugly to reported revenue while margins and recurring cash flow quietly improve underneath. Wall Street punishes that math every time, right up until a print forces the rethink.
August was that print, with a beat on both lines and a raised full-year outlook, and the shares still sit well under where the models place fair value. What you are buying is the boring middle of a transition that usually ends at a higher multiple than it started. Q3 in late October is your confirmation. Two clean quarters in a row and the discount stops being defensible.
Genpact (NYSE: G)
A new chief financial officer and a full artificial intelligence services suite landed in the same stretch, and the shares barely acknowledged either. That gets you a meaningful discount to fair value estimates on a business with genuinely high revenue visibility, because digital operations and consulting work is contracted rather than transactional.
Management has been aggressive with buybacks, which is the sort of thing that compounds quietly while nobody is looking. The AI services book is the part worth tracking, since it determines whether this stays a steady compounder or becomes something faster. Earnings in early November is the catalyst. Start here and add on any dip into the low thirties.
ON Semiconductor (NASDAQ: ON)
Investor Day lands Wednesday, and that is the entire near-term setup. Management is expected to lay out gross margin targets stretching to 2030, size up the data center opportunity, and give updated numbers on the Synaptics deal.
Shares still trade well off last year’s highs, so you are not paying up for a story that has already been told. The thing to watch is whether the margin path they present is credible rather than aspirational, because a believable 2030 bridge is what re-rates a power semiconductor business. Watch for weakness ahead of the event, since that is usually where the better entry sits.

Retirement Risk Revealed (Sponsored)
A well-known ratings firm just flagged a government retirement issue most investors haven't heard about yet.
Weiss Ratings has a track record of early warnings, including several major financial shifts over the past few decades.
Their research team put together a short briefing on what they're calling "Project Pyramid" and what it could mean for retirement accounts.
See what they found.

Fast Movers to Watch
Descartes Systems (NASDAQ: DSGX) This is the widest gap on the list and the draft had it buried at the bottom. Descartes runs logistics and supply chain software for roughly 29,000 customers, carries no debt, and trades at a substantial discount to fair value estimates after a recent decline.
Double-digit revenue growth with expanding margins on a debt-free balance sheet is not usually available at this kind of multiple.Roivant Sciences (NASDAQ: ROIV) Positive Phase 3 data for brepocitinib has already landed, and multiple late-stage readouts and regulatory decisions are still queued behind it.
What you own here is portfolio optionality trading at a discount to the sum of its parts, which means any single approval reprices the entire basket rather than one asset. This is a sit on your hands and wait position, not a trade.Kulicke and Soffa (NASDAQ: KLIC) Flagged because it sits marginally over your ceiling at roughly $86. The machines this company makes bond chips onto packages, which puts it directly in front of the chiplet and advanced packaging trend everyone credits for the AI accelerator boom.
Reported earnings still look soft coming through the cycle bottom, which is why the market is pricing legacy wire bonding rather than the advanced packaging inflection.

You'd rather buy…

Everything Else
Analysts screened every sector, chart, and earnings trend, and a free report names 10 stocks primed for a Fed-fueled rally in the second half of 2026.
Nvidia fell in premarket trading as fresh warnings from AI leaders about slowing the pace of development put some pressure on the massive spending cycle that has driven chip stocks higher.
Baldwin Insurance agreed to a $7.7 billion take-private deal led by Michael Dell’s DFO Management, with shareholders set to receive $32.50 per share in cash.
Kimberly-Clark is preparing potential asset sales to address European antitrust concerns around its $40 billion acquisition of Kenvue, adding another hurdle to the deal.
GSK climbed after reporting positive results from two lung-cancer drugs, Jideytro and Ris-Rez, giving investors another reason to focus on the company’s oncology pipeline.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any stocks you want me to check out.
Best Regards,
—Noah Zelvis
Undervalued Edge




